Research
Read how they describe their research on their University of Toronto profile.
Latest papers
Autologous stem cell transplant and combination immunotherapy of rituximab and interferon-α induces prolonged clinical and molecular remissions in patients with follicular lymphoma.
British journal of haematology · 2019 · senior author
Impact of central nervous system ( CNS ) prophylaxis on the incidence and risk factors for CNS relapse in patients with diffuse large B ‐cell lymphoma treated in the rituximab era: a single centre experience and review of the literature
British Journal of Haematology · 2012
Latest funding
- $761,176
A randomized controlled trial of early outpatient palliative care for patients with multiple myeloma
CIHR · 2026 · Co-investigator
2 publications.
Autologous stem cell transplant and combination immunotherapy of rituximab and interferon-α induces prolonged clinical and molecular remissions in patients with follicular lymphoma.
Smyth L, Buckstein R, Pennell N, Weerasinghe R, Cheung MC, Imrie K, Spaner D, Piliotis E, Chodirker L, Reis M, Ghorab Z, Zhang L, Boudreau V, Miliken A, Berinstein N
Impact of central nervous system ( CNS ) prophylaxis on the incidence and risk factors for CNS relapse in patients with diffuse large B ‐cell lymphoma treated in the rituximab era: a single centre experience and review of the literature
Hany R. Guirguis, Matthew C. Cheung, Mervat Mahrous, Eugenia Piliotis, Neil Lorne Berinstein, Kevin Imrie, Liying Zhang, Rena J. Buckstein
A randomized controlled trial of early outpatient palliative care for patients with multiple myeloma
Principal investigators: Hannon, Breffni
Keywords: Early Palliative Care; Malignant Hematology; Multiple Myeloma; Quality Of Life; Randomized Controlled Trial; Satisfaction With Care; Supportive Care; Symptom Control
From public funding decisions: CIHR since 2008, NSERC since 1991 and SSHRC since 1998 with their latest competition results, the Canada Foundation for Innovation, Genome Canada, the Canadian Space Agency, Canada Research Chairs, the Fonds de recherche du Québec, Ontario research funding, Michael Smith Health Research BC, the Canadian Cancer Society, Heart & Stroke and Brain Canada.
Frequent collaborators
- Lisa Chodirker and Matthew Cheung: 17 shared papers
- Rena Buckstein and Matthew Cheung: 13 shared papers
- David Spaner and Matthew Cheung: 12 shared papers
- Lisa Chodirker and Rena Buckstein: 6 shared papers
- David Spaner and Rena Buckstein: 5 shared papers
- David Spaner and Lisa Chodirker: 3 shared papers
- Lisa Chodirker and Zeina Ghorab: 2 shared papers
- Zeina Ghorab and Rena Buckstein: 2 shared papers
- Zeina Ghorab and Matthew Cheung: 2 shared papers
- Neil Berinstein and Rena Buckstein: 2 shared papers
- Neil Berinstein and Matthew Cheung: 2 shared papers
- David Spaner and Neil Berinstein: 1 shared paper
- Lisa Chodirker and Neil Berinstein: 1 shared paper
- Zeina Ghorab and Neil Berinstein: 1 shared paper
- Department of Medicine
- Department of Laboratory Medicine & Pathobiology
Co-authors at University of Toronto, colored by department. Thicker lines mean more shared papers; select anyone to open their profile and their own map.
Rena Buckstein
Department of Medicine
2 shared papers, latest 2019
Matthew Cheung
Department of Medicine
2 shared papers, latest 2019
Kevin Imrie
Critical Care Medicine
2 shared papers, latest 2019
David Spaner
Department of Medicine
1 shared papers, latest 2019
Lisa Chodirker
Department of Medicine
1 shared papers, latest 2019
Zeina Ghorab
Department of Laboratory Medicine & Pathobiology
1 shared papers, latest 2019
A short, specific email works best. This draft uses one of their recent papers; replace the parts in brackets with your own details before sending.
Profile data last refreshed on September 29, 2026 from the university directory, publication records and public research funding records.